MSLP.Q logo

MusclePharm Corporation Stock Price

OTCPK:MSLP.Q Community·US$33.0 Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

MSLP.Q Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Price US$0

MSLP.Q Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low with weak fundamentals.

3 Risks
0 Rewards

MusclePharm Corporation Key Details

US$50.0m

Revenue

US$46.8m

Cost of Revenue

US$3.2m

Gross Profit

US$22.5m

Other Expenses

-US$19.3m

Earnings

Last Reported Earnings
Mar 31, 2022
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About MSLP.Q

Founded
2006
Employees
n/a
CEO
Eric Hillman
WebsiteView website
www.musclepharm.com

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada. On December 15, 2022, MusclePharm Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Nevada.

Recent MSLP.Q News & Updates

Recent updates

No updates